EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Magnetoelectric biofeedback for precision-targeted rectocele management: A randomized controlled trial of phenotype-driven pelvic floor neuromodulation

Hong Zhi Geng, Chen Xu, Jiying Cong, Yuwei Li

International Journal of Colorectal Disease · 05.03.2026 · 41 (1)

DOI: 10.1007/s00384-026-05110-0 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 05.03.2026. Verfasst von Hong Zhi Geng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anorectal Surgery, Hepu People's Hospital, Guangxi Zhuang Autonomous Region, 95 Dinghai North Road, Beihai City, 536100, China. Hauptthemen laut MEDLINE: Rectocele, Pelvic Floor, Biofeedback, Psychology, Precision Medicine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Tianjin Key Medical Discipline (Specialty) Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Magnetoelectric biofeedback therapy (MEBFT) is an emerging intervention for moderate rectocele-associated obstructed defecation syndrome (ODS); however, its efficacy and mechanisms remain unclear. This study compared MEBFT with conventional biofeedback therapy (BFT) and developed a 3D high-resolution anorectal manometry (HR-ARM)-based predictive model for clinical decision-making. METHODS: In this prospective, single-blind, randomized controlled trial, 68 female patients with defecography-confirmed moderate rectocele-associated ODS were treated in the outpatient department of Tianjin Union Medical Center from January 2019 to June 2024). Patients were randomly assigned in a 1:1 ratio to either the MEBFT or BFT group. Primary outcomes included 3D HR-ARM parameters, Glazer surface electromyography, and patient-reported outcomes (Cleveland Clinic Constipation and Patient Assessment of Constipation Quality of Life scores) at baseline and 3 months. The secondary outcomes included predictive indicators derived from the Hosmer-Rothman model and treatment response stratification. RESULTS: MEBFT significantly improved fast-twitch fiber recruitment, anorectal function, and quality of life compared to BFT (all P < 0.01). The Hosmer-Rothman model identified a negative MRP-MTV interaction (synergy index = 0.20), with the R11 phenotype (MRP < 80 mmHg-MTV < 135 cc) predicting an 82.35% response to MEBFT after 3 months of treatment (area under the curve [AUC] = 0.72). Phenotypic stratification-guided management: R11 for MEBFT, R00 (elevated MRP-MTV) for surgical evaluation, and R10/R01 for extended MEBFT with surgical backup. CONCLUSIONS: MEBFT demonstrated superior clinical effectiveness, anorectal functional recovery, and quality of life compared with BFT after 3 months of treatment. The exploratory Hosmer-Rothman model may provided a moderate-accuracy phenotype-based approach using 3D HR-ARM parameters to stratify treatment response and optimize the individualized management of moderate rectocele-associated ODS. TRIAL REGISTRATION: 1. Date of registration (needs to be before the Date of the First Patient): December 26, 2023. 2. Date of initial participant enrollment: January 9, 2019. 3. Clinical trial identification number: ChiCTR2300079173. 4. URL of the registration site: http://www.chictr.org.cn/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RectocelePelvic FloorBiofeedback, PsychologyPrecision MedicineHumansFemalePhenotypeMiddle AgedQuality of LifeManometryTreatment OutcomeConstipationAdultDefecationProspective Studies

Stichwörter der Autor:innen

BiofeedbackManometryObstructed defecationPhenotypic stratificationRectocele

Autor:innen und Institutionen

  • Department of Anorectal Surgery, Hepu People's Hospital, Guangxi Zhuang Autonomous Region, 95 Dinghai North Road, Beihai City, 536100, China.
  • Department of Colorectal Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University, Tianjin Institute of Coloproctology, 190 Jieyuan Road, Hongqiao District, Tianjin, 3…

Förderung

  • National Natural Science Foundation of China
  • Tianjin Key Medical Discipline (Specialty) Construction Project

Zitieren

APA

Geng, H. Z., Xu, C., Cong, J., & Li, Y. (2026). Magnetoelectric biofeedback for precision-targeted rectocele management: A randomized controlled trial of phenotype-driven pelvic floor neuromodulation. International Journal of Colorectal Disease, 41(1). https://doi.org/10.1007/s00384-026-05110-0

Vancouver

Geng HZ, Xu C, Cong J, Li Y. Magnetoelectric biofeedback for precision-targeted rectocele management: A randomized controlled trial of phenotype-driven pelvic floor neuromodulation. International Journal of Colorectal Disease. 2026;41(1). doi:10.1007/s00384-026-05110-0

BibTeX
@article{Geng2026,
  author = {Geng, Hong Zhi and Xu, Chen and Cong, Jiying and Li, Yuwei},
  title = {Magnetoelectric biofeedback for precision-targeted rectocele management: A randomized controlled trial of phenotype-driven pelvic floor neuromodulation},
  journal = {International Journal of Colorectal Disease},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1007/s00384-026-05110-0}
}
Kostenlos starten →